Stacey Renfro Takes Career to Next Level as EVP, Chief Customer and Digital Experience Officer

Stacey Renfro will be joining The Vitamin Shoppe in the newly constructed role of executive vice president, chief customer and digital experience officer. Renfro brings to The Vitamin Shoppe over two decades of experience as an omnichannel retail executive with proven experience developing and implementing successful digital, e-commerce, customer experience and sales strategies.

"I am impressed with the passion of all The Vitamin Shoppe Health Enthusiasts and the history of providing knowledgeable and great customer service,” Renfro said. “I am very excited to be joining The Vitamin Shoppe to help drive the digital agenda as it relates to enhancing the customer shopping experience and driving sales. This is a key component to advancing and growing The Vitamin Shoppe's relevancy to today's retail environment."

Renfro was most recently EVP, planning & aAllocations at Pier 1 Imports. Prior to that role she spent five years (2013-2018) leading the e-commerce and customer experience transformation at Pier 1. From 2004 through 2013, she was employed at JCPenney in roles of increasing responsibility, primarily in e-commerce, culminating in her last position as divisional vice president, digital commerce.

"Stacey has a long history of strengthening a company's competitive position and relevance through developing and executing customer-driven strategies across all channels which makes her an ideal choice to help us take the business to the next level,” said The Vitamin Shoppe CEO Sharon Leite. “The Vitamin Shoppe is undergoing a period of significant change, with a substantial focus on an improved customer experience, a key strategic driver of the organization's future. As chief customer and digital experience officer, Stacey will be responsible for aligning and leveraging The Vitamin Shoppe's capabilities across multiple channels and functions to ensure we are meeting the evolving needs of today's customer.” 

Renfro’s appointment will become official on November 5, 2018.